- 1Department of Cardiac Surgery, Peking University Third Hospital, Beijing, China
- 2Research Center of Clinical Epidemiology, Peking University Third Hospital, Beijing, China
- 3Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing, China
A Correction on
By Gong Y, Wang X, Li N, Fu Y, Zheng H, Zheng Y, Zhan S and Ling Y (2022). Front. Cardiovasc. Med. 9:804217. doi: 10.3389/fcvm.2022.804217
At the inception of this RCT, the study was registered under the number NCT04795193. Due to adjustments in team responsibilities and unfamiliarity with clinical trial registration rules, a revised protocol was mistakenly submitted as a separate registration under NCT05104320. This registration number was then used during the submission of the protocol manuscript. Upon subsequent verification of the RCT, we discovered this inconsistency and intend to consolidate the information from both registration entries into the original registration under NCT04795193, while withdrawing the duplicate registration NCT05104320. The registration number “NCT05104320” in the published article should be replaced with “NCT04795193.”
A correction has been made to the sentence in section Materials and Methods, paragraph 1:
“This randomized patient preference trial had been registered at ClinicalTrials.gov, identifier: NCT04795193.”
The original version of this article has been updated.
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: MICS-CABG, patients' preference, quality of life, patency rate, trial, minimally invasive, surgical procedures, SF-36 score
Citation: Gong Y, Wang X, Li N, Fu Y, Zheng H, Zheng Y, Zhan S and Ling Y (2025) Correction: A partially randomized patient preference trial to assess the quality of life and patency rate after minimally invasive cardiac surgery-coronary artery bypass grafting: design and rationale of the MICS-CABG PRPP trial. Front. Cardiovasc. Med. 12:1713150. doi: 10.3389/fcvm.2025.1713150
Received: 25 September 2025; Accepted: 16 October 2025;
Published: 31 October 2025.
Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland
Copyright: © 2025 Gong, Wang, Li, Fu, Zheng, Zheng, Zhan and Ling. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Yunpeng Ling, bWljc2xpbmdAMTYzLmNvbQ==; Siyan Zhan, c2l5YW4temhhbkBiam11LmVkdS5jbg==
†These authors have contributed equally to this work
‡These authors share senior authorship
Yichen Gong1,†